Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giaccone

Showing results (251-260 of 359) with videos related to

Pageof 36
Sort By:
Biochimica Et Biophysica Acta|December 27, 1995
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lungG Giaccone, J van Ark-Otte, G Scagliotti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 18, 2009
An atypical case of sporadic fatal insomniaL Priano, G Giaccone, M Mangieri, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell linesA F Gazdar, C Kadoyama, D Venzon, et al.
The American Journal of Pathology|March 1, 1996
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumorsM A Izquierdo, G L Scheffer, M J Flens, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Critical Reviews in Oncology/Hematology|October 18, 2000
The multilayered postconfluent cell culture as a model for drug screeningJ M Padrón, C L van der Wilt, K Smid, et al.
International Journal of Cancer|May 29, 1997
Expression of drug resistance proteins in breast cancer, in relation to chemotherapyS C Linn, H M Pinedo, J van Ark-Otte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumorsG Giaccone, S C Linn, J Welink, et al.
Current Pharmaceutical Design|September 15, 2012
Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumorsJ Voortman, T Harada, R P Chang, et al.
Neurology|November 1, 1989
Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected familyB Ghetti, F Tagliavini, C L Masters, et al.
Pageof 36

Showing results (251-260 of 359) with videos related to

Sort By:
Pageof 36
Biochimica Et Biophysica Acta|December 27, 1995
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lungG Giaccone, J van Ark-Otte, G Scagliotti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 18, 2009
An atypical case of sporadic fatal insomniaL Priano, G Giaccone, M Mangieri, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell linesA F Gazdar, C Kadoyama, D Venzon, et al.
The American Journal of Pathology|March 1, 1996
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumorsM A Izquierdo, G L Scheffer, M J Flens, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Critical Reviews in Oncology/Hematology|October 18, 2000
The multilayered postconfluent cell culture as a model for drug screeningJ M Padrón, C L van der Wilt, K Smid, et al.
International Journal of Cancer|May 29, 1997
Expression of drug resistance proteins in breast cancer, in relation to chemotherapyS C Linn, H M Pinedo, J van Ark-Otte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumorsG Giaccone, S C Linn, J Welink, et al.
Current Pharmaceutical Design|September 15, 2012
Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumorsJ Voortman, T Harada, R P Chang, et al.
Neurology|November 1, 1989
Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected familyB Ghetti, F Tagliavini, C L Masters, et al.
Pageof 36